Sorafenib is the first drug approved to treat advanced hepatocellular carcinoma (HCC) and
continues as the gold-standard therapy against HCC. However, acquired drug resistance …

While the neuronal underpinnings of autism spectrum disorder (ASD) are being unraveled,
vascular contributions to ASD remain elusive. Here, we investigated postnatal …

This study investigated the therapeutic effects of the phytochemical crocin alone or in
combination with sorafenib both in rats chemically induced with hepatocellular carcinoma …

Liver cancer is one of the leading causes of cancer deaths worldwide. Among all primary
liver cancers, hepatocellular carcinoma (HCC) is the most common type, representing 75 …

Simple Summary Hepatocellular carcinoma (HCC) is sometimes diagnosed at an advanced
stage, with subsequent complex therapeutic efforts combining both locoregional and …

Purpose To determine the tumor immune cell landscape after transcatheter arterial bland
embolization (TAE) in a clinically relevant rat hepatocellular carcinoma (HCC) model …

Embolic agents used in transarterial embolization for intermediate stage hepatocellular
carcinoma reduce blood flow into tumors and can deliver anticancer drugs. Tumor blood …

Purpose To compare the difference of evaluating the microcirculatory function status of
primary small HCC between DCE-MRI with two-compartmental pharmacokinetic model and …

In this study, single-and dual-targeted gadolinium-carbon dots (Gd-CDs) with Bevacizumab
(BEV) and/or folic acid (FA) were developed as dual-modal fluorescence and magnetic …

This review aimed to perform a scoping review of promising MRI methods in assessing
tumor hypoxia in hepatocellular carcinoma (HCC). The hypoxic microenvironment and …